Relmada Therapeutics
RLMD
RLMD
91 hedge funds and large institutions have $40.3M invested in Relmada Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $66.6M → $40.3M (-$26.3M)
66% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 29
Holders
91
Holding in Top 10
–
Calls
$307K
Puts
$162K
Top Buyers
| 1 | +$1.87M | |
| 2 | +$1.38M | |
| 3 | +$779K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$417K |
| 5 |
GIM
Guild Investment Management
Los Angeles,
California
|
+$358K |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$822K | |
| 3 | -$728K | |
| 4 |
HF
HRT Financial
New York
|
-$552K |
| 5 |
Morgan Stanley
New York
|
-$486K |